Bleeding management for pediatric craniotomies and craniofacial surgery

Paediatric Anaesthesia

Volumn 24, Issue 7, 2014, Pages 678-689

  Goobie, Susan M ^a   Haas, Thorsten ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

antifibrinolytics; bleeding management; blood loss; craniofacial; craniotomy; pediatric neurosurgery

Indexed keywords

FRESH FROZEN PLASMA;

ANESTHESIA; BLEEDING; BLOOD CONSERVATION; BLOOD TRANSFUSION; CRANIOFACIAL SURGERY; CRANIOTOMY; ERYTHROCYTE TRANSFUSION; FLUID THERAPY; HEMOSTASIS; HUMAN; PATHOPHYSIOLOGY; PEDIATRIC SURGERY; PEROPERATIVE CARE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE TRANSFUSION; BLOOD LOSS, SURGICAL; CHILD; CRANIOFACIAL ABNORMALITIES; HEMORRHAGE; INTRAOPERATIVE COMPLICATIONS; NEUROSURGERY; PEDIATRICS; PLASTIC SURGERY; PROCEDURES;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHILD; CRANIOFACIAL ABNORMALITIES; CRANIOTOMY; HEMORRHAGE; HUMANS; INTRAOPERATIVE COMPLICATIONS; NEUROSURGICAL PROCEDURES; PEDIATRICS; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 84902357145     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/pan.12416     Document Type: Review

References (103)

1. Koh JL, Egan B, McGraw T,. Pediatric epilepsy surgery: anesthetic considerations. Anesthesiol Clin 2012; 30: 191-206.
2. Flack S, Ojemann J, Haberkern C,. Cerebral hemispherectomy in infants and young children. Pediatr Anesth 2008; 18: 967-973.
3. White N, Marcus R, Dover S, et al,. Predictors of blood loss in fronto-orbital advancement and remodeling. J Craniofac Surg 2009; 20: 378-381.
4. Goobie SM, Proctor MR, Meara JG, et al,. Can we predict which infants have more adverse events post craniofacial surgery? 15th Congress of the International Society of Craniofacial Surgery; Jackson Hole, Wyoming 2013.
5. Faraoni D, Goobie SM,. Efficacy of antifibrinolytic agents in children undergoing non-cardiac surgery: a systematic review of the literature. Anesth Analg 2014; 118: 628-636.
6. Goobie SM, Soriano SG, Zurakowski D, et al,. Hemostatic changes in pediatric neurosurgical patients as evaluated by thrombelastograph. Anesth Analg 2001; 93: 887-892.
7. Gerlach R, Krause M, Seifert V, et al,. Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochir (Wien) 2009; 151: 873-900; discussion.
8. Tsuda H, Oka K, Noutsuka Y, et al,. Tissue-type plasminogen activator in patients with intracranial meningiomas. Thromb Haemost 1988; 60: 508-513.
9. Prasad KS, Sharma BS, Marwaha N, et al,. Haemostatic derangement in patients with intracranial tumours. Br J Neurosurg 1994; 8: 695-702.
10. Edgington TS,. Activation of the coagulation system in association with neoplasia. J Lab Clin Med 1980; 96: 1-4.
11. Haas T, Mauch J, Weiss M, et al,. Management of dilutional coagulopathy during pediatric major surgery. Transfus Med Hemother 2012; 39: 114-119.
12. Bolliger D, Gorlinger K, Tanaka KA,. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113: 1205-1219.
13. Fenger-Eriksen C, Anker-Moller E, Heslop J, et al,. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005; 94: 324-329.
14. Levy JH, Szlam F, Tanaka KA, et al,. Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding. Anesth Anag 2012; 114: 261-274.
15. Stricker PA, Shaw TL, Desouza DG, et al,. Blood loss, replacement, and associated morbidity in infants and children undergoing craniofacial surgery. Pediatr Anesth 2010; 20: 150-159.
16. Cosgriff N, Moore EE, Sauaia A, et al,. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma 1997; 42: 857-861.
17. Bhananker SM, Ramamoorthy C, Geiduschek JM, et al,. Anesthesia-related cardiac arrest in children: update from the Pediatric Perioperative Cardiac Arrest Registry. Anesth Analg 2007; 105: 344-350.
18. Stainsby D, Jones H, Wells AW, et al,. Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996-2005. Br J Haematol 2008; 141: 73-79.
19. Lavoie J,. Blood transfusion risks and alternative strategies in pediatric patients. Pediatr Anesth 2011; 21: 14-24.
20. Society of Pediatric Anesthesia. Hyperkalemia statement www.pedsanesthesia.org 2011. Available at: www.wakeupsafe.org/hyperkalemia- statement.pdf. Accessed 15 January, 2014.
21. Lee AC, Reduque LL, Luban NL, et al,. Transfusion-associated hyperkalemic cardiac arrest in pediatric patients receiving massive transfusion. Transfusion 2014; 54: 244-254.
22. World Health Organization. Sixty-third World Health Assembly WHA63/2010/REC/1, Resolutions and decisions 2010. 2010. Available at: http://apps.who.int/gb/ebwha/pdf-files/WHA63-REC1/WHA63-REC1-en.pdf. Accessed 15 January, 2014.
23. The American Medical Association. Proceedings from the National Summit On Overuse 2012. Available at: www.ama-assn.org/resourses/doc/cqi/overuse- proceedings-paper.pdf. Accessed 15 January, 2014.
24. World Health Organization 2014. Available at: www.who.int/medical- devices/initiatives/anaemia-control/en/. Accessed 15 January, 2014.
25. Shander A, Ozawa S, Gross I, et al,. Erythropoiesis-stimulating agents: friends or foes? Transfusion 2013; 53: 1867-1872.
26. Naran S, Cladis F, Fearon J, et al,. Safety of preoperative erythropoietin in surgical calvarial remodeling: an 8-year retrospective review and analysis. Plast Reconstr Surg 2012; 130: 305e-310e.
27. Meneghini L, Zadra N, Aneloni V, et al,. Erythropoietin therapy and acute preoperative normovolaemic haemodilution in infants undergoing craniosynostosis surgery. Paediatr Anaesth 2003; 13: 392-396.
28. Goodnough LT, Shander A,. Current status of pharmacologic therapies in patient blood management. Anesth Analg 2013; 116: 15-34.
29. Lauder GR,. Pre-operative predeposit autologous donation in children presenting for elective surgery: a review. Transfus Med 2007; 17: 75-82.
30. Goldman M, Savard R, Long A, et al,. Declining value of preoperative autologous. Transfusion 2002; 42: 819-823.
31. Pietrini D,. Intraoperative management of blood loss during craniosynostosis surgery. Pediatr Anesth 2013; 23: 278-280.
32. Dirkmann D, Hanke AA, Gorlinger K, et al,. Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg 2008; 106: 1627-1632.
33. Secher EL, Stensballe J, Afshari A,. Transfusion in critically ill children: an ongoing dilemma. Acta Anaesthesiol Scand 2013; 57: 684-691.
34. Bolliger D, Tanaka KA,. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev 2013; 27: 213-220.
35. Haas T, Goobie S, Spielmann N, et al,. Improvements in patient blood management for pediatric craniosynostosis surgery using a ROTEM -assisted strategy-feasibility and costs. Pediatr Anesth 2014.
36. Fearon JA,. Reducing allogenic blood transfusions during pediatric cranial vault surgical procedures: a prospective analysis of blood recycling. Plast Reconstr Surg 2004; 113: 1126-1130.
37. Dahmani S, Orliaguet GA, Meyer PG, et al,. Perioperative blood salvage during surgical correction of craniosynostosis in infants. Br J Anaesth 2000; 85: 550-555.
38. Waters JH,. Indications and contraindications of cell salvage. Transfusion 2004; 44 (12 Suppl): 40S-44S.
39. McCluskey SA, Karkouti K, Wijeysundera D, et al,. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg 2013; 117: 412-421.
40. Butterworth JF, Mythen MG,. Should "normal" saline be our usual choice in normal surgical patients? Anesth Analg 2013; 117: 290-291.
41. Van Der Linden P, James M, Mythen M, et al,. Safety of modern starches used during surgery. Anesth Analg 2013; 116: 35-48.
42. Perel P, Roberts I,. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2011; (3): CD000567.
43. Finfer S, Bellomo R, Boyce N, et al,. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-2256.
44. Bailey AG, McNaull PP, Jooste E, et al,. Perioperative crystalloid and colloid fluid management in children: where are we and how did we get here? Anesth Analg 2010; 110: 375-390.
45. Wilkes MM, Navickis RJ, Sibbald WJ,. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001; 72: 527-533; discussion 34.
46. de Jonge E, Levi M,. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001; 29: 1261-1267.
47. Haas T, Preinreich A, Oswald E, et al,. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia 2007; 62: 1000-1007.
48. Perel P, Roberts I,. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007; (4): CD000567.
49. Stricker PA, Fiadjoe JE, Davis AR, et al,. Reconstituted blood reduces blood donor exposures in children undergoing craniofacial reconstruction surgery. Pediatr Anesth 2011; 21: 54-61.
50. Hildebrandt B, Machotta A, Riess H, et al,. Intraoperative fresh-frozen plasma versus human albumin in craniofacial surgery-a pilot study comparing coagulation profiles in infants younger than 12 months. Thromb Haemost 2007; 98: 172-177.
51. Stanworth SJ, Brunskill SJ, Hyde CJ, et al,. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126: 139-152.
52. Puetz J, Witmer C, Huang YS, et al,. Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effect. J Pediatr 2012; 160: 210-215 e1.
53. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208.
54. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al,. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270-382.
55. The Canadian Medical Association Expert Working Group. Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J, 1997; 156 (11 suppl): S1-S24.
56. Stainsby D, MacLennan S, Thomas D, et al,. Guidelines on the management of massive blood loss. Br J Haematol 2006; 135: 634-641.
57. Lacroix J, Hebert PC, Hutchison JS, et al,. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356: 1609-1619.
58. Morley SL,. Red blood cell transfusions in acute paediatrics. Arch Dis Child Educ Pract Ed 2009; 94: 65-73.
59. Hume HA, Limoges P,. Perioperative blood transfusion therapy in pediatric patients. Am J Ther 2002; 9: 396-405.
60. Hillyer CD, Josephson CD, Blajchman MA, et al,. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program 2003; 575-589.
61. Gonzalez EA, Moore FA, Holcomb JB, et al,. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007; 62: 112-119.
62. Borgman MA, Spinella PC, Perkins JG, et al,. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-813.
63. Spinella PC, Perkins JG, Grathwohl KW, et al,. Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. J Trauma 2008; 64 (2 Suppl): S69-S77.
64. Roback JD, Caldwell S, Carson J, et al. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010; 50: 1227-1239.
65. Kozek-Langenecker SA,. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 2010; 24: 27-40.
66. Romlin BS, Wahlander H, Synnergren M, et al,. Earlier detection of coagulopathy with thromboelastometry during pediatric cardiac surgery: a prospective observational study. Pediatr Anesth 2013; 23: 222-227.
67. Haas T, Spielmann N, Mauch J, et al,. Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012; 108: 36-41.
68. Oswald E, Stalzer B, Heitz E, et al,. Thromboelastometry (ROTEM) in children: age-related reference ranges and correlations with standard coagulation tests. Br J Anaesth 2010; 105: 827-835.
69. Miller BE, Bailey JM, Mancuso TJ, et al,. Functional maturity of the coagulation system in children: an evaluation using thrombelastography. Anesth Analg 1997; 84: 745-748.
70. Rossaint R, Bouillon B, Cerny V, et al,. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14: R52.
71. Fenger-Eriksen C, Moore GW, Rangarajan S, et al,. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010; 50: 2571-2576.
72. Gibson BE, Todd A, Roberts I, et al,. Transfusion guidelines for neonates and older children. Br J Haematol 2004; 124: 433-453.
73. Haas T, Fries D, Velik-Salchner C, et al,. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008; 106: 725-731, table of contents.
74. Ziegler B, Schimke C, Marchet P, et al,. Severe pediatric blunt trauma-successful ROTEM-guided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets. Clin Appl Thromb Hemost 2013; 19: 453-459.
75. Kozek-Langenecker S, Sorensen B, Hess JR, et al,. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011; 15: R239.
76. Dickneite G, Pragst I, Joch C, et al,. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 2009; 20: 535-540.
77. FDA. Human Fibrinogen Concentrate, Pasteurized (Riastap) Indication: For the treatment of congenital fibrinogen deficiency. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM162780.pdf. Accessed 15 January, 2014.
78. ™ Distribution www.blood.ca. Customer Letter 2013-04. Available at: http://www.bloodservices.ca/CentreApps/Internet/UW-V502- MainEngine.nsf/resources/CustomerLetters2013/&x0024;file/CL2013-04.pdf. Accessed 15 January, 2014.
79. Haas T, Korte W, Spielmann N, et al,. Perioperative course of FXIII in children undergoing major surgery. Pediatr Anesth 2012; 22: 641-646.
80. Gertler R, Martin K, Hapfelmeier A, et al,. The perioperative course of factor XIII and associated chest tube drainage in newborn and infants undergoing cardiac surgery. Pediatr Anesth 2013; 23: 1035-1041.
81. Goerlinger K, Dirkmann D, Hanke AA, et al,. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179-1191.
82. Schoechl H, Maegele M, Solomon C, et al,. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012; 20: 15.
83. Simpson E, Lin Y, Stanworth S, et al,. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012; (3): CD005011.
84. Goobie SM,. The case for the use of tranexamic acid. Pediatr Anesth 2013; 23: 281-284.
85. Goobie SM, Meier PM, Pereira LM, et al,. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. Anesthesiology 2011; 114: 862-871.
86. Dadure CSM, Bringuier S, et al,. Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: a randomized double-blind study. Anesthesiology 2011; 114: 856-861.
87. Goobie SM, Meier PM, Sethna NF, et al,. Population pharmacokinetics of tranexamic Acid in paediatric patients undergoing craniosynostosis surgery. Clin Pharmacokinet 2013; 52: 267-276.
88. Stricker PA, Zuppa AF, Fiadjoe JE, et al,. Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery. Br J Anaesth 2013; 110: 788-799.
89. Oppenheimer AJ, Ranganathan K, Levi B, et al,. Minimizing transfusions in primary cranial vault remodeling: the role of aminocaproic Acid. J Craniofac Surg 2014; 25: 82-86.
90. Pharmacia and Upjohn Co DoP, inventor. Cyklokapron Drug Description. New York, NY: Pharmacia and Upjohn Co DoP, 2008.
91. Xanodyne Pharmaceuticals I, inventor. Amicar Package Insert. Newport, KY: Xanodyne Pharmaceuticals I, 2005.
92. Winter SS, Chaffee S, Kahler SG, et al,. epsilon-Aminocaproic acid-associated myopathy in a child. J Pediatr Hematol Oncol 1995; 17: 53-55.
93. Breuer T, Martin K, Wilhelm M, et al,. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. Eur J Cardiothorac Surg 2009; 35: 167-171; author reply 71.
94. Murkin JM, Falter F, Granton J, et al,. High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110: 350-353.
95. Kalavrouziotis D, Voisine P, Mohammadi S, et al,. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 2012; 93: 148-154.
96. Lecker I, Wang DS, Romaschin AD, et al,. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 2012; 122: 4654-4666.
97. Ahmed Z, Stricker L, Rozzelle A, et al,. Aprotinin and transfusion requirements in pediatric craniofacial surgery. Pediatr Anesth 2014; 24: 141-145.
98. D'Errico CC, Munro HM, Buchman SR, et al,. Efficacy of aprotinin in children undergoing craniofacial surgery. J Neurosurg 2003; 99: 287-290.
99. Goobie S,. Should Aprotinin be reconsidered for use in pediatric surgery? Pediatr Anesth 2014; 24: 137-140.
100. Gaberel T, Magheru C, Emery E, et al,. Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis. Acta Neurochir (Wien) 2012; 154: 1-9; discussion.
101. Thomas G, Evelyne E,. Antifibrinolytic in subarachnoid hemorrhage. Neurosurgery 2011; 69: E505-E507.
102. Germans MR, Post R, Coert BA, et al,. Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial. Trials 2013; 14: 143.
103. Dewan Y, Komolafe EO, Mejia-Mantilla JH, et al,. CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials 2012; 13: 87.